In pharma delivery, size matters. So, too, do the intricacies of dosage
format, active ingredient compatibility, and effective delivery to
patients—whatever their needs or preferences may be.
Yet standard dosage forms haven’t always provided companies the
options, flexibility, or performance to bring all those puzzle pieces
together during therapeutic development.
We spoke with Nathan H. Dormer, PhD, Director of Drug Product
Development at Adare Pharma Solutions, to learn how this new
technology platform is expanding the frontiers of therapeutic delivery
and improving patients’ experience in the process.
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains how her team managed the study’s strict −80 °C handling requirement, quality release, and site readiness, and how the Almac Adapt approach can apply beyond this program.
The FDA grants accelerated approval to subcutaneous amivantamab for head and neck cancer, extending the IV-to-subcutaneous shift in biologics formulation.
Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.
Vivek Gupta of Duquesne University explains at AAPS PharmSci 360 why device decisions can't wait and why excipient makers must test beyond drug molecules.
